NCT01613287 - Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

November 30, 2013

Conditions

Idiopathic Pulmonary Arterial Hypertension

Interventions

DEVICE

TheraSorb® - Ig flex

"TheraSorb® Treatment with one TheraSorb® Ig flex adsorber pair, used exclusively with the LIFE 18® apheresis system for extracorporeal application for IA therapy.~5 treatments performed over 5 to 8 consecutive days."

Trial Locations (4)

13353

Deutsches Herzzentrum Berlin, Klinik für Herz-, Thorax- und Gefäßchirurgie, Berlin

17475

Universitätsmedizin Greifswald, Zentrum für Innere Medizin, Klinik und Poliklinik für Innere Medizin B, Greifswald

50937

Herzzentrum der Universität zu Köln, Klinik III für Innere Medizin und Zentrum für Molekulare Medizin, Cologne

69126/ 69120

Thoraxklinik am Universitätsklinikum Heidelberg in cooperation with Nierenzentrum Heidelberg, Heidelberg

All Listed Sponsors

lead

Miltenyi Biotec B.V. & Co. KG

INDUSTRY